Search

Search Results

3 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 17, Issue 5pp 1313-1327

  Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis

  Relevance score: 0.00

  Henry WC Leung, Mei-Ching Tsai, Shin-Hang Leung, Shyh-Yau Wang, Agnes LF Chan

  Keywords: breast cancer, elderly patients, abemaciclib, ribociclib, palbociclib, network meta-analysis

  Published in Aging on May 25, 2025

  Show abstract
• Research PaperVolume 9, Issue 12pp 2695-2716

  A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas

  Relevance score: 0.00

  Djihad Hadjadj, Su-Jung Kim, Thomas Denecker, Laura Ben Driss, Jean-Charles Cadoret, Chrystelle Maric, Giuseppe Baldacci, Fabien Fauchereau

  Keywords: cancer, CDK6, adrenocortical, palbociclib, ribociclib

  Published in Aging on December 26, 2017

  Show abstract
• EditorialVolume 9, Issue 8pp 1859-1860

  The transcriptome of CDK4/6 inhibition

  Relevance score: 0.00

  Erik S. Knudsen, Agnieszka K. Witkiewicz

  Keywords: cyclin D1, RB, E2F, retinoblastoma, palbociclib, abemaciclib, ribociclib, CDK4/6

  Published in Aging on August 30, 2017